Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC
Clinical trial NCT00519831 · TERMINATED
Trial details
- NCT number
- NCT00519831
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2008-02-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.